Core Group members

Andrew Peacock is Director of the Scottish Pulmonary Vascular Unit, which looks after all the 5 million patients with pulmonary hypertension in Scotland, UK. He is also Professor in Medicine at the University of Glasgow (Respiratory Medicine). Dr Peacock trained at St Bartholomew's Hospital Medical College and Brompton Hospital, London, UK, and at the University of Colorado Health Sciences Center, Denver, CO, USA.

Hypoxia remains the main theme of his research, because it enables him to combine the science of the pulmonary circulation with an unhealthy interest in mountains. His laboratory studies the effects of hypoxia on pulmonary vascular-cell proliferation and on the physiological responses of the human pulmonary circulation. He has been involved in many of the clinical trials of new therapies for pulmonary hypertension in the past few years, and has spent time developing new end-points in the assessment of patients with pulmonary vascular disease.

Dr Peacock is Secretary of the Pulmonary Circulation Group of the European Respiratory Society and the author of more than 150 papers, reviews, and chapters on pulmonary vascular disease. He is co-editor with Lew Rubin of Pulmonary Circulation: diseases and their treatments (2nd Edition).